{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:46:54Z","timestamp":1788266814145,"version":"build-2803163510"},"reference-count":20,"publisher":"IMR Press","issue":"12","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["BK20240370"],"award-info":[{"award-number":["BK20240370"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Suzhou Basic Research Pilot Project","award":["SSD2024075"],"award-info":[{"award-number":["SSD2024075"]}]},{"name":"Bo Xi Foundation","award":["BXQN202231"],"award-info":[{"award-number":["BXQN202231"]}]},{"name":"Science and Technology Development Foundation of Nanjing Medical University","award":["NMUB20220189"],"award-info":[{"award-number":["NMUB20220189"]}]},{"name":"Suzhou Science and Technology Bureau Project","award":["SKY2023199"],"award-info":[{"award-number":["SKY2023199"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Psoriasis is a chronic and incurable skin inflammation driven by an abnormal immune response. Our study aims to investigate the potential of interferon-\u03b3 (IFN-\u03b3) primed mesenchymal stem cells (IMSCs) in targeting T cells to attenuate psoriasis-like inflammation, and to elucidate the underlying molecular mechanism involved. Methods: Mesenchymal stem cells (MSCs) were isolated from the umbilical cord and identified based on their surface markers. Psoriasis models were established and then treated with IMSCs. Flow cytometry analysis was used to examine cell surface markers and T cell percentages. Indoleamine-2,3-dioxygenase (IDO) was knocked down by small interfering RNA (siRNA) and examined with western blot assay. The proliferative capacity of T cells was assessed using water-soluble tetrazolium salt-1(WST-1). Additionally, an immunohistochemical assay was used to determine epidermal thickness. The psoriasis area and severity index (PASI) scores were also assessed. Results: We observed significant therapeutic efficacy of IMSCs against psoriasis-like inflammation in mice. Treatment with IMSCs resulted in a notable reduction in T cell infiltration within psoriatic lesions. Furthermore, we demonstrated that the therapeutic efficacy was mediated by the upregulation of IDO through IFN-\u03b3 stimulation. In vitro, IDO inhibited T cell proliferation, and in vivo, the therapeutic efficacy was eliminated when MSCs were transfected with IDO siRNA. Conclusion: IMSCs can treat psoriasis by suppressing T cell infiltration and the suppression is mediated by IDO.<\/jats:p>","DOI":"10.31083\/j.fbl2912411","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:37:01Z","timestamp":1735558621000},"source":"Crossref","is-referenced-by-count":3,"title":["Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-\u03b3 Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation"],"prefix":"10.31083","volume":"29","author":[{"given":"Weidong","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Kim N, Jeong YG, Lee S, Kang J, Kim Y, Choi YA, et al. Ameliorated Skin Inflammation through the Synergistic Effect of Gold Nanorod-Dexamethasone and Photothermal Therapy. ACS Applied Materials & Interfaces. 2024; 16: 12217\u201312231.","DOI":"10.1021\/acsami.3c16919"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Walter K. Psoriasis. JAMA. 2022; 327: 1936.","DOI":"10.1001\/jama.2022.5270"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet (London, England). 2021; 397: 1301\u20131315.","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Roesner LM, Farag AK, Pospich R, Traidl S, Werfel T. T-cell receptor sequencing specifies psoriasis as a systemic and atopic dermatitis as a skin-focused, allergen-driven disease. Allergy. 2022; 77: 2737\u20132747.","DOI":"10.1111\/all.15272"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nature Reviews. Disease Primers. 2016; 2: 16082.","DOI":"10.1038\/nrdp.2016.82"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Li B, Huang L, Lv P, Li X, Liu G, Chen Y, et al. The role of th17 cells in psoriasis. Immunologic Research. 2020; 68: 296\u2013309.","DOI":"10.1007\/s12026-020-09149-1"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Guo D, Li X, Wang J, Liu X, Wang Y, Huang S, Dang N. Single-cell RNA-seq reveals keratinocyte and fibroblast heterogeneity and their crosstalk via epithelial-mesenchymal transition in psoriasis. Cell Death & Disease. 2024; 15: 207.","DOI":"10.1038\/s41419-024-06583-z"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Chen Y, Huang Y, Li J, Jiao T, Yang L. Enhancing osteoporosis treatment with engineered mesenchymal stem cell-derived extracellular vesicles: mechanisms and advances. Cell Death & Disease. 2024; 15: 119.","DOI":"10.1038\/s41419-024-06508-w"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nature Immunology. 2014; 15: 1009\u20131016.","DOI":"10.1038\/ni.3002"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Xu C, Feng C, Huang P, Li Y, Liu R, Liu C, et al. Tnfalpha and ifngamma rapidly activate pi3k-akt signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property. Stem Cell Research & Therapy. 2022; 13: 491.","DOI":"10.1186\/s13287-022-03178-3"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhang J, Lu Y, Mao Y, Yu Y, Wu T, Zhao W, et al. Ifn-\u03b3 enhances the efficacy of mesenchymal stromal cell-derived exosomes via mir-21 in myocardial infarction rats. Stem Cell Research & Therapy. 2022; 13: 333.","DOI":"10.1186\/s13287-022-02984-z"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, et al. Kynurenic acid, an ido metabolite, controls tsg-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death & Differentiation. 2018; 25: 1209\u20131223.","DOI":"10.1038\/s41418-017-0006-2"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Smith CH, Yiu ZZN, Bale T, Burden AD, Coates LC, Edwards W, et al. British association of dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update. British Journal of Dermatology. 2020; 183: 628\u2013637.","DOI":"10.1111\/bjd.19039"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmunity Reviews. 2022; 21: 103169.","DOI":"10.1016\/j.autrev.2022.103169"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Gong P, Ding Y, Sun R, Jiang Z, Li W, Su X, et al. Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages. Cell Death Discovery. 2022; 8: 466.","DOI":"10.1038\/s41420-022-01264-2"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Xu F, Fei Z, Dai H, Xu J, Fan Q, Shen S, et al. Mesenchymal stem cell-derived extracellular vesicles with high pd-l1 expression for autoimmune diseases treatment. Advanced Materials. 2022; 34: e2106265.","DOI":"10.1002\/adma.202106265"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2: 141\u2013150.","DOI":"10.1016\/j.stem.2007.11.014"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Francis L, Capon F, Smith CH, Haniffa M, Mahil SK. Inflammatory memory in psoriasis: From remission to recurrence. The Journal of Allergy and Clinical Immunology. 2024; 154: 42\u201350.","DOI":"10.1016\/j.jaci.2024.05.008"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Nussbaum L, Chen YL, Ogg GS. Role of regulatory t cells in psoriasis pathogenesis and treatment. British Journal of Dermatology. 2021; 184: 14\u201324.","DOI":"10.1111\/bjd.19380"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Reviews. Immunology. 2004; 4: 762\u2013774.","DOI":"10.1038\/nri1457"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/12\/10.31083\/j.fbl2912411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:48:43Z","timestamp":1735559323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/12\/10.31083\/j.fbl2912411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2768-6701(24)01490-4"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2912411","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"article-number":"411"}}